Stargardt disease is a rare genetic eye disease that happens when fatty material builds up on the macula. An overview of the rationale for the use of omega-3 fatty acids in patients with Stargardt disease and dry age-related macular degeneration are discussed in this touchOPHTHALMOLOGY interview with Dr Katerina Prokopiou (University of Nicosia Medical School, Engomi, Cyprus) as well as the unmet needs of therapeutic interventions in patients with vision loss due to retinal degeneration.
The presentation entitled ‘A prospective, multicentre, randomised, double-blind study designed to assess the potential effects of omega-3 fatty acids supplementation in dry age-related macular degeneration or Stargardt disease’ was presented at the The Association for Research in Vision and Ophthalmology, May 01-04, 2022
Questions:
- What are the challenges and unmet needs of therapeutic interventions in patients with vision loss due to retinal degeneration?
- What is the rationale for the use of omega-3 fatty acids in patients with dry age-related macular degeneration or Stargardt disease?
Disclosures: Katerina Prokopiou has nothing to disclose in relation to this video.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Shanice Allen.
Filmed in coverage of the virtual ARVO 2022.
